[两例由燃烧的草和米的烟雾引起的喘病例]
Hiroaki Kume1, Riko Sato1, Ryuki Yamada1
1Department of Respiratory Medicine, Fukushima Medical University Aizu Medical Center.
Arerugi = [Allergy]
|February 11, 2026
概括
暴露在燃烧的草和其他环境触发因素中的挥发性有机化合物 (VOC) 可能会导致喘. 这项研究强调了VOC诱导的喘和Symbicort的有效治疗.
科学领域:
- 环境健康 环境健康
- 肺部病理学 肺部病理学
- 毒理学 毒理学 毒理学
背景情况:
- 患者呈现出呼吸道症状,如呼吸不全,咳和喘息.
- 症状因季节性暴露于日本常见的燃烧大米和的烟雾而恶化.
- 其他触发因素包括香,百合和空气清新剂,所有这些都含有挥发性有机化合物 (VOC).
研究的目的:
- 调查VOC暴露和喘发展之间的联系.
- 诊断和管理由环境刺激因素引发的喘.
- 为了评估VOC诱导喘患者的治疗疗效.
主要方法:
- 两名患有呼吸道症状的患者的临床表现分析.
- 肺功能测试,包括1秒内强制呼气量 (FEV1) 和甲胆挑战测试.
- 评估外围乙氨基酸细胞数量和部分呼出的氧化 (FeNO) 含量.
- 对Symbicort (布塞索尼德/形式特醇) 的治疗反应的评估.
主要成果:
- 两位患者均被诊断为由VOCs引发的喘.
- 观察到可变的空气流阻塞 (FEV1波动>0.6L).
- 通过甲胆挑战,在一名患者中证实了气道过敏反应.
- 没有升高的乙氨基酸或FeNO,排除了乙氨基酸性炎症.
- 辛比科特疗法有效降低了全身皮质类固醇剂量.
结论:
- 来自环境来源的挥发性有机化合物 (VOC),如燃烧的草,可以诱发喘.
- 喘的表现可能包括可变的气流阻塞和气道过敏反应.
- 用Symbicort治疗是有效的管理VOC诱导的喘和减少类固醇依赖.
相关概念视频
Burn Injuries
4.6K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.6K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-II: Pathophysiology and Classification
4.5K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.5K


